111, Inc. (YI)
NASDAQ: YI · Real-Time Price · USD
5.65
-0.38 (-6.24%)
At close: Sep 17, 2025, 4:00 PM EDT
5.65
0.00 (0.00%)
After-hours: Sep 17, 2025, 4:04 PM EDT
111, Inc. Market Cap
111, Inc. has a market cap or net worth of $48.97 million as of September 17, 2025. Its market cap has decreased by -37.00% in one year.
Market Cap
48.97M
Enterprise Value
16.23M
1-Year Change
-37.00%
Ranking
Category
Stock Price
$5.65
Market Cap Chart
Since September 12, 2018, 111, Inc.'s market cap has decreased from $1.11B to $48.97M, a decrease of -95.60%. That is a compound annual growth rate of -35.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 52.23M | -2.13% |
| Dec 31, 2024 | 53.37M | -59.01% |
| Dec 29, 2023 | 130.19M | -48.23% |
| Dec 30, 2022 | 251.48M | -13.30% |
| Dec 31, 2021 | 290.06M | -49.33% |
| Dec 31, 2020 | 572.40M | 4.16% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Sep 12, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 670.92B |
| Johnson & Johnson | 426.47B |
| AbbVie | 383.15B |
| UnitedHealth Group | 315.99B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 238.00B |
| Abbott Laboratories | 229.10B |